Insmed (INSM) PT Raised to $208 at Stifel: Arikayce Peak Sales Revised Upwards

March 24, 2026 6:56 AM

Stifel analyst Stephen Willey raised the price target on Insmed (NASDAQ: INSM) to $208.00 (from $205.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found